Starlake Bioscience Co Inc Zhaoqing Guangdong Financial Flexibility Index
Starlake Bioscience Co Inc Zhaoqing Guangdong financial flexibility index. Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of CN¥1.90 Billion (operating CF CN¥1.25 Billion minus capex CN¥652.49 Million) represents 0% of total liabilities (CN¥8.77 Billion). Explore 600866 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Financial flexibility index of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. Historical Financial Flexibility Index trend for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. Check Starlake Bioscience Co Inc Zhaoqing Guan investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Starlake Bioscience Co Inc Zhaoqing Guangdong Financial Flexibility Index by Year (1998–2025)
Starlake Bioscience Co Inc Zhaoqing Guangdong financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Starlake Bioscience Co Inc Zhaoqing Guangdong. For the full cash flow conversion analysis, see Starlake Bioscience Co Inc Zhaoqing Guan cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥3.33 Billion | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -18.6% |
| 2024 | 0.47x | CN¥3.04 Billion | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +30.4% |
| 2023 | 0.36x | CN¥2.40 Billion | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +53.2% |
| 2022 | 0.23x | CN¥2.11 Billion | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -59.1% |
| 2021 | 0.57x | CN¥397.71 Million | CN¥192.63 Million | CN¥697.74 Million | ▼ -20.5% |
| 2020 | 0.72x | CN¥539.88 Million | CN¥249.99 Million | CN¥752.97 Million | ▲ +15.3% |
| 2019 | 0.62x | CN¥370.58 Million | CN¥213.17 Million | CN¥595.95 Million | ▲ +260.2% |
| 2018 | 0.17x | CN¥84.40 Million | CN¥50.69 Million | CN¥488.94 Million | ▲ +14.4% |
| 2017 | 0.15x | CN¥80.66 Million | CN¥40.05 Million | CN¥534.57 Million | ▲ +18.2% |
| 2016 | 0.13x | CN¥81.43 Million | CN¥41.17 Million | CN¥637.90 Million | ▼ -4.4% |
| 2015 | 0.13x | CN¥106.23 Million | CN¥2.75 Million | CN¥795.88 Million | ▲ +279.4% |
| 2014 | 0.04x | CN¥27.70 Million | CN¥-20.22 Million | CN¥787.37 Million | ▼ -46.2% |
| 2013 | 0.07x | CN¥74.46 Million | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +568.5% |
| 2012 | 0.01x | CN¥16.62 Million | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -98.3% |
| 2011 | 0.57x | CN¥925.40 Million | CN¥65.88 Million | CN¥1.62 Billion | ▼ -20.4% |
| 2010 | 0.72x | CN¥501.03 Million | CN¥104.63 Million | CN¥698.07 Million | ▼ -9.7% |
| 2009 | 0.79x | CN¥379.33 Million | CN¥316.73 Million | CN¥477.36 Million | ▲ +131.9% |
| 2008 | 0.34x | CN¥198.90 Million | CN¥148.93 Million | CN¥580.44 Million | ▲ +32.4% |
| 2007 | 0.26x | CN¥157.18 Million | CN¥82.28 Million | CN¥607.29 Million | ▲ +18.9% |
| 2006 | 0.22x | CN¥112.52 Million | CN¥35.14 Million | CN¥516.89 Million | ▼ -8.6% |
| 2005 | 0.24x | CN¥116.60 Million | CN¥46.83 Million | CN¥489.57 Million | ▼ -60.8% |
| 2004 | 0.61x | CN¥249.81 Million | CN¥29.05 Million | CN¥410.86 Million | ▼ -37.6% |
| 2003 | 0.97x | CN¥259.83 Million | CN¥149.70 Million | CN¥266.82 Million | ▼ -32.2% |
| 2002 | 1.44x | CN¥271.37 Million | CN¥183.18 Million | CN¥188.89 Million | ▲ +155.7% |
| 2001 | 0.56x | CN¥138.17 Million | CN¥60.82 Million | CN¥245.97 Million | ▲ +16.0% |
| 2000 | 0.48x | CN¥160.58 Million | CN¥93.41 Million | CN¥331.53 Million | ▼ -47.4% |
| 1999 | 0.92x | CN¥132.42 Million | CN¥52.97 Million | CN¥143.87 Million | ▼ -17.6% |
| 1998 | 1.12x | CN¥184.87 Million | CN¥71.14 Million | CN¥165.54 Million | — |